Psychedelics Today

In this week's Solidarity Fridays episode, Kyle, Joe, and Michelle first discuss an article from Salon.com that illustrates the flaws behind psychedelics being continually hailed as a miracle cure: has everyone just replaced the oft-criticized model of selling a “miracle” pill with selling the narrative that a few psychedelic sessions can cure anything? And inspired by Lenny Gibson, they point out that this rabid focus on medicalization is a direct result of these substances being made illegal in the first place. What would things look like if that had never happened? They then cover the developing drama between Compass Pathways and seemingly anyone compassionate and not making money from Compass Pathways' seedy behavior, represented this week by Tim Ferriss and David Bronner. The latest update includes Compass co-founder Christian Angermayer calling Ferriss' millions in donations a "drop in the ocean" in an odd donations-measuring contest, an email sent to investors saying competitors will never be able to b

In this episode, Joe interviews the most guests he's ever had on at once- 5 people from the Entheo Society of Washington: Leo Russell (Executive Director), Monique Bridges (Head of the Female Battalion and Head Guardian of the Santo Daime Ayahuasca Church), Malika Lamont (Director of VOCAL Washington), Tatiana (a lot of day-to-day duties that sound like project management), and Solana Booth (promoter and teacher of traditional Native American healing techniques and modalities).   The Entheo Society of Washington is a 501c3 organization and sister agency to Decriminalize Nature Seattle that is working to create community and treatment centers and eventually a movie about the underground psychedelic culture in the Pacific Northwest (in addition to their obvious fight for the decriminalization of entheogens). Their larger, more socially-focused goals are to encourage people to reconnect to the earth, accept our emotions more, hold space for healing and encourage others to do the same, see the economy around lega

In last week's Solidarity Fridays episode, Kyle, Joe, and Michelle talked a lot about a landmark new trial to study microdosing and the placebo effect. And this week (the big SF50!), they're joined by 2 key members of that very trial, lead researcher Balázs Szigeti and principal investigator David Erritzoe.  Szigeti and Erritzoe explain all the factors of the trial in great detail: how participants blinded themselves and the complications with capsule weight (and burping?), what substances participants took, how they were able to track which participants were in which group, what "breaking blind" meant specific to this trial, how they essentially used cognitive performance tests as a control, how depression factored in (or didn't), why they specifically chose people with experience in psychedelics, and why this study mimics real-life microdosing so perfectly. And they talk about the fascinating results: that while across the board, people scored better and felt better after microdosing for 4 weeks, the people

In this episode, with his recent salvia experience in mind, Kyle interviews creator of the salvia pipe, and somatic salvia guide working to bring mindfulness to salvia use, Christopher Solomon. To many of us, the word "salvia" conjures up images of one or both of the following: smoking salvia with friends and having a panicked, out-of-body experience that (rightfully) scared us away from ever doing it again, or watching Youtube videos of people filming themselves doing the same. Solomon's goal is to reframe salvia's reputation from one of confusion and panic back to how it's known to the Mazatec people who discovered its power: as a loving, empathetic healer.  He talks about his first time smoking salvia after meditating and meeting a female entity, the differences between smoking, chewing leaves, and drinking a tincture, virtual salvia sessions, why you should smoke tiny amounts of salvia repetitively rather than 50x bong hits, why so many people feel like they’re zippers while on salvia, and his thoughts (a

In today’s Solidarity Fridays episode, Kyle, Joe, and Michelle once again meet through the airwaves to discuss recent news articles and see where that takes them.  They first talk about a North Wales police boss who wants to give prisoners controlled amounts of cannabis as a way to combat violence and drug addiction and how that questions the notion of prisoners being expected to suffer. Then, they head to "Missurah," where a bill was just introduced to remove their established provision against Schedule I substances, expanding eligibility and getting them closer to how other states use 2018's federal Right to Try Act to help people with terminal and life-threatening illnesses. They then talk about a study that showed significant reduction in alcohol consumption after MDMA use and why the sense of connection that MDMA fosters could be the reason, a self-blinding microdosing study that proved the power of the placebo (and expectation) effect and what that might mean for regular microdosers, and a listener emai

In this episode, Joe interviews the founder and CEO of MindMed, JR Rahn. This one's a bit different and plays out perhaps unsurprisingly, as Joe's well-established talking points against the drug war and DEA, legalize-everything stance, and all-inclusive focus on the many branches of drug-use (medical/therapeutic use, religious use, celebration/partying, inner work and exploration, and creative problem-solving) meet an addict businessman whose life was saved by psychedelics and who doesn't want to talk about the battle but instead wants to push forward, all-in on the method he thinks will get people in need the medicine that could save them the fastest: not putting so much effort towards state-by-state decriminalization and demonizing the DEA, but instead, working with them towards medicalization, and telling them what we want by passing measures that allocate more capital and resources towards infrastructure that will help people.  Rahn talks about what MindMed is working on: the first approved commercial dr

In today’s Solidarity Fridays episode, Kyle and Joe are joined once again from Mexico by Michelle Janikian, and let's take a moment to do what wasn't done last week: welcome Michelle to the podcast, as she will be joining the guys on SFs for the foreseeable future, and possibly on other podcasts soon as well. Welcome to the revolution, Michelle! As you’d expect, they discuss the news: Norway's plan to decriminalize personal drug use based on recommendations from the U.N. and W.H.O. and why that may be related to Norway's high rate of drug-related deaths (or maybe even a high suicide rate), a new bill in California to not only decriminalize psychedelics (including MDMA and LSD, and excluding peyote) but expunge records as well, a new Massachusetts bill to decriminalize all drugs and study psychedelics, a study where researchers achieved real-time communication with lucid dreamers, and Alex Jones' (likely true) claim that government officials regularly use DMT to communicate with freaking aliens. The most-discu

In this episode, Kyle interviews clinical psychologist focusing on sexual trauma, health, and identity, and author of The Psychedelics Integration Handbook, Dr. Ryan Westrum. Westrums' biggest focus and conversation with clients right now in our age of Covid concerns who we are without medicine- how we fill the liminal states between our sessions or rituals. He talks a lot about the work people can do on their own now: learning to listen to our inner healers, honing and sharpening what we already know, stretching ourselves, listening to the different parts of our intuition (our physical bodies, emotional hearts, and cognitive thinking) and realigning when one is out of sync, and maybe the most important lesson: embracing the idea that self-work doesn't have to be built on trials and tribulations, and often, challenging ourselves to use our hands and practicing something we know we're good at or getting back into a long-forgotten hobby can be just as effective towards growth and feeling better about ourselves.

In today’s Solidarity Fridays episode, Kyle and Joe are joined from Mexico by freelance journalist (who has been featured here several times) and writer of Your Psilocybin Mushroom Companion, Michelle Janikian. They first get into an email from a listener in Costa Rica highlighting a problem Michelle has seen in Mexico (and that mirrors last week's discussion about ayahuasca gatherings): expats' disregard for Covid safety protocols showing an egotistical disrespect for the communities that have welcomed them. The episode then shifts to a bit of a callback to the early days of solidarity, with fewer philosophical ponderings and a whole lot of articles (just scroll down to view the wall of links). From ketamine reducing suicidality (and is ketamine a cure-all silver bullet or just an overhyped respite?) to a Rick Strassman-backed study of DMT for stroke patients, to a college in Jamaica opening a Field-Trip backed psilocybin lab, to Vermont and New Jersey's progress on decriminalization bills, to a discussion o

In this episode, Kyle interviews board-certified heart and lung transplant surgeon and author, most recently of The Art of Human Care, Dr. Hassan Tetteh. Tetteh talks about his book, a "manifesto of sorts" about what human care is in relation to what we traditionally see in standard health care and how the model is rooted in empathy and listening, and was inspired greatly by both his near-death experience with bacterial meningitis (and seeing what it was like to be a helpless patient) and his work with transcendental meditation (which has helped him deal with past trauma and connect him more with the here and now). He talks about his Human Care "LEARN" framework, an amazing "Death Over Dinner" experience where he and randomly-assigned strangers contemplated 3 simple (but not so simple) questions over dinner, how he sees death as a doctor and as someone who came close to death himself, how to discover what a patient's purpose is, and why he's excited about psychedelics becoming medicines. Notable Quotes “I’ve

In today’s Solidarity Fridays episode, Kyle and Joe cover several news stories, including the University of Wisconsin-Madison creating a Psychoactive Pharmaceutical Investigation masters program, a non-profit called the Healing Advocacy Fund being created to implement therapeutic-use psilocybin in Oregon, legislature in Hawaii filing a new bill to legalize therapeutic-use psilocybin and psilocin (and remove them from their Schedule I controlled substances list), Cambridge, Massachusetts joining its neighbor, Somerville, in decriminalizing entheogenic plants, and the biggest story: Compass Pathways attempting to patent such common aspects of psilocybin-assisted therapy as soft furniture, muted colors, and providing "reassuring physical contact." This leads to a discussion on patents and what companies are really trying to do with this behavior.  They then discuss why mescaline isn't researched more, why psychedelic exceptionalism is a problem, Dr. Carl Hart, The Weeknd, and one of everyone's favorite topics: t

In this episode, Joe interviews Vancouver-based serial entrepreneur, co-founder, president, and CEO of Better Plant Sciences Inc., and founder and CEO of NeonMind Biosciences, Penny White.  White works to take companies public, and was running Better Plant Sciences before creating NeonMind as a subsidiary, largely inspired by Michael Pollan and research by scientists at the University of British Columbia who were looking to treat addiction with CBD.  Now that NeonMind has successfully gone public (which just happened at the end of December), her goals with the company are to develop a protocol around using psilocybin to tackle obesity (they're in pre-clinical trials now and have 5 patents filed), to work more with medicinal mushrooms and sell products with proven health claims (they sell mushroom coffees now), and eventually get into work involving drug addiction and preventing the effects of Alzheimer's- also likely with psilocybin.  This podcast feels like a meeting of 2 minds fully immersed in the psychede

In today’s Solidarity Fridays episode, Kyle and Joe first talk about some great news stories pushing forward the psychedelic movement: Massachusetts General Hospital creating the Center for Neuroscience of Psychedelics with backing from Atai Life Sciences, Florida pushing forward a bill to establish a legal therapeutic-use psilocybin model similar to Oregon's (with a task force responsible for studying psilocybin), Connecticut pushing forward their own much simpler bill to establish their own psilocybin-studying task force, and a recent study using fMRI to examine brain connectivity that found that under the influence of LSD, the relationship between anatomy and brain structure on brain function (similar to phrenology) weakens, thereby allowing the brain to explore other functional connectivity patterns.  They then dive into the hot and oddly polarizing topic of ayahuasca centers continuing to hold ceremonies with as many as 80 people and 3 sessions a week during a time when people should be doing their best

In this episode, Kyle and Joe interview Dr. Matthew Johnson: Professor at Johns Hopkins, writer of the recent paper, "Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine," and researcher (with others) on several trials through Johns Hopkins involving psilocybin: for smoking cessation, anorexia, mood and effects of early-stage Alzheimer's, opioid addiction, post-treatment Lyme disease syndrome, co-morbid alcoholism with depression, and soon, LSD for chronic pain.  Johnson talks about his paper, which largely deals with the ambiguity of the term "consciousness" and how it applies to David Chalmers' hard problem, and asks many philosophical questions: What is consciousness? What is phenomenal consciousness? Are things that seem like you actually similar? Do they have similar experiences or agency? How would you even know? If you built a robot that displays perfectly human-like qualities similar to yours and appears to have agency and experience, does it? Can you prove that it doesn't?  They also

In today’s Solidarity Fridays episode, Kyle (or "Jimmy New Jersey")'s spot is taken by Vermont-based filmmaker Colin Thompson, and Joe interviews him about his newest movie, "Light Years," released in 2019 with help from Free Association (Channing Tatum's production company).  Thompson, a very sarcastic and down-to-earth writer and director, talks about his past films, the trials and tribulations of making a movie and trying to sell it, how Free Association got involved, Phish, Rickie Lee Jones, and the importance of good music to film, how a heroic dose of mushrooms and a sunrise hike helped him complete the movie, why there aren't more psychedelic films, and how it came to be that he ended up playing nearly every part in a movie that he originally didn't want to be in at all.  “Light Years” is summarized on imdb.com as: "A thirty-something man goes on an annual cosmic vision quest to visit a dead friend. But a stick gets stuck in the spokes of his psychedelia and in every face, friends and family alike, his

In this episode, Joe interviews Director of ecological think tank The Institute of Ecotechnics, and publisher and CEO of Synergetic Press, Deborah Snyder. Snyder talks about her past- meeting people from the Institute of Ecotechnics at a conference about the solar system, time working with Richard Evans Schultes, participating in a traveling theatre company, and the early days of the Heraclitus (a research ship built for a 2-year expedition through the Amazon, which is now being rebuilt to soon visit and chronicle remote coastal cultures). She also discusses Biosphere 2, ecotechnics (the discipline of relating the technosphere to the biosphere), regenerative agriculture, and the idea of natural capital- assigning economic (or other) value to an ecosystem as a way of both identifying keys to ecological longevity and increasing corporate or governmetal interest in the environment.  She talks about books she's published or work she's been inspired by from a veritable who's-who of names listeners of this podcast

In today’s Solidarity Fridays episode, Kyle and Joe cover a crazy story about a man who injected psilocybin tea, only to end up having fungi grow in his blood and put him into organ failure. They question the logistics of this and wonder if it’s ever happened before, but Joe has since found an article reporting that this did happen back in 1985. So as crazy as it seems, it is absolutely possible. Be careful out there, folks. They then talk about how the current psychedelic rush is diluting the existing culture, and how we should react to it, comparing it to "Eternal September," the Usenet term for when AOL started mailing out internet disks to millions, providing access to Usenet, and how that affected the long-established and tight-knit Usenet community. This leads to a discussion of what tends to happen in the black market when cannabis is legalized, what lawyers will likely be doing in this space, why outlaw behavior is so attractive to people, and how "plant medicines" is too broad of a term to be used fo

In this episode, Joe interviews Dr. Anne Wagner: Toronto-based clinical psychologist, founder of Remedy (a mental health clinic combining therapy with research through their corresponding Remedy Institute), investigator on the MAPS-sponsored trial on cognitive behavioral conjoint therapy for PTSD, and current lead investigator on MAPS' trial of cognitive processing therapy + MDMA for PTSD.  She talks about working with Candice Monson in 2013, having her first MDMA therapy session with Michael and Annie Mithoefer a year later, her first couples study on PTSD using MDMA, her MAPS training (she's now a trainer in-training), her passion for relational healing, Remedy and what she hopes to accomplish there, and what she'd like to do next: a larger MDMA couples therapy study with hopes of proving its efficacy towards relationship satisfaction improvement to the point of running a study without PTSD being a factor, and a new protocol combining mindfulness-based work with psilocybin.  They also talk about the idea of

In today’s Solidarity Fridays episode, Kyle and Joe talk about last week's incident at the US Capitol and point out that the most recognizable figure from the protest calls himself a shaman and promotes the use of psychedelics.  This leads to a discussion about how we in the psychedelic community like to believe that psychedelics lead to connection, self-actualization, and love, but they can also lead to crazy ideas, an openness to conspiracy theories, and other dark paths. They talk about how they both went down conspiracy rabbit holes for years, but ultimately came to the realization that while it was all interesting and aligned with their distrust of the government, they couldn't prove any of the conspiracies they were spending so much time looking into, and even if they could, would that really better their lives or the community around them?  They talk about where we’ve arrived as a culture in terms of trust in the government and other authoritarian institutions, how we're dealing with an unending stream

In this episode, Kyle interviews psychologist and licensed marriage and family therapist, Veronika Gold, and author and clinical psychologist, Harvey Schwartz. They are co-founders (and Gold is the CEO) of Polaris Insight Center in San Francisco, which offers ketamine-assisted psychotherapy. Together, they work as co-therapists, as trainers on ketamine-assisted psychotherapy through Polaris Insight Center, and as investigators in MAPS' Phase 3 MDMA-assisted psychotherapy clinical trial for the treatment of PTSD.  They talk about their training model, the benefits of co-therapy and how a leader/apprentice co-therapy model is likely the future of therapy training, the importance of doing your own work as a therapist, the arguments for therapists not taking drugs, the subtle hierarchal and approval-seeking games uncovered in training, how working with ketamine today is like raising a teenager, the "mystery and mastery" in therapy, medicine, and psychedelics, and the casualties of the mental health care system an